
Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers researchers.
“Binge eating disorder is the most common eating disorder in the United States, yet there is no drug specifically developed for the condition that affects people of all racial and ethnic groups," said Abanoub Armanious, a master of science student at Rutgers School of Public Health and lead author of the study.

Rutgers School of Public Health recently celebrated the success of Expressions of Community: A Workplace Program of Mind and Body Wellness. This unique initiative, led by Michelle Ruidíaz-Santiago, executive assistant in the Department of Health Behavior, Society, and Policy, and John Ciampi, administrative assistant in the Department of Health, Behavior, and Society, was funded by a Rutgers Health Joy at Work grant.

In a commentary published in JAMA, experts at the Rutgers Institute for Nicotine & Tobacco Studies have issued a call to action to head off the proliferation of nicotine pouches based on lessons learned from electronic-cigarette regulation.